A University of Arizona Cancer Center researcher was awarded a $1.3 million grant from the National Cancer Institute to study the effectiveness of lifestyle interventions in American Indian patients with obesity-related solid tumor cancers who are preparing for surgery.
Sanofi and Regeneron’s blockbuster Dupixent rejected by FDA for chronic hives condition
US regulators want to see more efficacy data before they consider approving Sanofi and Regeneron’s Dupixent in a skin condition characterized by chronic hives, Sanofi